Bayview Legacy, Llc Sells 70,000 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 70,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $31.20, for a total value of $2,184,000.00. Following the transaction, the insider directly owned 9,049,071 shares in the company, valued at approximately $282,331,015.20. This represents a 0.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Wednesday, April 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $19.04, for a total value of $1,332,800.00.
• On Tuesday, March 10th, Bayview Legacy, Llc sold 9,000 shares of Arteris stock. The shares were sold at an average price of $14.66, for a total value of $131,940.00.
• On Monday, March 9th, Bayview Legacy, Llc sold 41,000 shares of Arteris stock. The shares were sold at an average price of $14.21, for a total value of $582,610.00.

Arteris Trading Up 9.6%

Shares of NASDAQ AIP opened at $35.55 on Thursday. The stock has a market cap of $1.64 billion, a price-to-earnings ratio of -45.00 and a beta of 1.93. Arteris, Inc. has a 1-year low of $6.88 and a 1-year high of $36.17. The stock’s 50-day moving average is $20.74 and its 200 day moving average is $17.31.

Arteris (NASDAQ:AIP) last announced its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million for the quarter, compared to analysts’ expectations of $21.03 million. On average, analysts forecast that Arteris, Inc. will post -0.68 EPS for the current fiscal year.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris beat Q1 expectations, posting a smaller loss than forecast and revenue above estimates, which suggests better operating momentum than investors had expected. Article Title
• Positive Sentiment: Management raised second-quarter and full-year 2026 revenue guidance, reinforcing confidence in near-term demand and growth outlook. Article Title
• Positive Sentiment: Rosenblatt Securities raised its price target on AIP from $20 to $38 and reiterated a buy rating, signaling a much more constructive view of the stock’s upside. Article Title
• Neutral Sentiment: The company’s earnings call materials and transcript may provide additional detail on margins, customer wins, and growth drivers, but they do not yet change the main investment thesis. Article Title
• Negative Sentiment: Major shareholder and CEO Bayview Legacy, LLC sold 70,000 shares, which can create some concern about insider confidence despite the sale being relatively small versus its remaining stake. Article Title

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on AIP. Rosenblatt Securities raised their price objective on Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a report on Wednesday. TD Cowen lifted their price target on Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research note on Monday, April 20th. Wall Street Zen cut Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, Northland Securities set a $38.00 price target on Arteris in a research note on Wednesday. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $37.75.

Hedge Funds Weigh In On Arteris

A number of large investors have recently bought and sold shares of AIP. Westerly Capital Management LLC increased its stake in Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after purchasing an additional 745,000 shares during the period. Nuveen LLC grew its position in shares of Arteris by 872.3% in the 4th quarter. Nuveen LLC now owns 737,281 shares of the company’s stock worth $11,428,000 after buying an additional 661,454 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Arteris by 144.7% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after buying an additional 598,840 shares during the period. Granahan Investment Management LLC increased its stake in shares of Arteris by 725.7% during the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock valued at $6,278,000 after buying an additional 546,341 shares during the period. Finally, Informed Momentum Co LLC purchased a new position in shares of Arteris during the fourth quarter valued at approximately $5,755,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.